Drug Profile
TAK 137
Alternative Names: AMPA receptor potentiator - Takeda; TAK-137Latest Information Update: 04 Aug 2015
Price :
$50
*
At a glance
- Originator Takeda
- Class Neuropsychotherapeutics
- Mechanism of Action AMPA receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Attention-deficit hyperactivity disorder; Neurological disorders; Psychiatric disorders
Most Recent Events
- 15 May 2015 Discontinued - Phase-I for Attention-deficit hyperactivity disorder (In adults) in USA (PO)
- 15 May 2015 Discontinued - Phase-I for Neurological disorders (In volunteers) in USA (PO)
- 15 May 2015 Discontinued - Phase-I for Psychiatric disorders (In volunteers) in USA (PO)